Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study. Academic Article uri icon

Overview

abstract

  • Purpose:

publication date

  • September 1, 2023

Identity

Scopus Document Identifier

  • 85168925187

Digital Object Identifier (DOI)

  • 10.1200/JCO.22.02766

PubMed ID

  • 37643542

Additional Document Info

volume

  • 41

issue

  • 25